Colitis, Ulcerative

• 

  Subject Areas on Research

  • A novel murine model of inflammatory bowel disease and inflammation-associated colon cancer with ulcerative colitis-like features. 
  • A prospective evaluation of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis. 
  • A review of rectal biopsy. 
  • A whole animal chemical screen approach to identify modifiers of intestinal neutrophilic inflammation. 
  • ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. 
  • AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. 
  • Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. 
  • Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. 
  • Adrenoleukodystrophy associated with vitiligo and ulcerative colitis. 
  • Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease. 
  • Antibiotics exposure and risk of inflammatory bowel disease: a systematic review. 
  • Asymptomatic transient uveitis in children with inflammatory bowel disease. 
  • Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease. 
  • Bile duct carcinoma associated with ulcerative colitis. 
  • Cancer of the bile ducts associated with ulcerative colitis. 
  • Capsule endoscopy performed across the pediatric age range: indications, incomplete studies, and utility in management of inflammatory bowel disease. 
  • Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. 
  • Crohn's disease IRGM risk alleles are associated with altered gene expression in human tissues. 
  • Current management of pediatric inflammatory bowel disease. 
  • Development of IgA and IgG2 subclass deficiency after sulfasalazine therapy. 
  • Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis. 
  • Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis? 
  • Emerging treatments for ulcerative colitis: a systematic review. 
  • Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. 
  • Gastrointestinal dysfunction in the critically ill: nutritional implications. 
  • Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases. 
  • Guidelines for immunizations in patients with inflammatory bowel disease. 
  • Health-related quality of life after ileoanal pull-through evaluation and assessment of new health status measures. 
  • Hemolytic anemia in patients receiving sulfasalazine. 
  • Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology. 
  • Identification of pathologic features associated with "ulcerative colitis-like" Crohn's disease. 
  • Ileal pouch-anal anastomosis for ulcerative colitis and familial adenomatous polyposis: historical development and current status. 
  • Ileostomy adenocarcinomas in the setting of ulcerative colitis. 
  • Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum. 
  • Immunosuppressive/Autoimmune Disorders. 
  • Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study. 
  • Induction of the tumor-suppressor p16(INK4a) within regenerative epithelial crypts in ulcerative colitis. 
  • Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex Life. 
  • Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. 
  • Intraoperative disseminated intravascular coagulation in a patient with ulcerative colitis. 
  • Is colorectal cancer surveillance cost-effective in patients with ulcerative colitis? 
  • John M. Kinney International Award for General Nutrition. Glutamine, heat shock protein, and inflammation--opportunity from the midst of difficulty. 
  • Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care. 
  • Litaf/Simple protein is increased in intestinal tissues from patients with CD and UC, but is unlikely to function as a transcription factor. 
  • Long-Term Outcomes in Indeterminate Colitis Patients Undergoing Ileal Pouch-Anal Anastomosis: Function, Quality of Life, and Complications. 
  • Nicotine as a therapeutic drug. 
  • Ocular Surface Epithelial Atypia Mimicking Squamous Neoplasia in Association With Ulcerative Colitis. 
  • Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial. 
  • Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses. 
  • Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis. 
  • Patient preferences for surgical versus medical therapy for ulcerative colitis. 
  • Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. 
  • Pneumorrhachis, subcutaneous emphysema, pneumomediastinum, pneumopericardium, and pneumoretroperitoneum after proctocolectomy for ulcerative colitis: report of a case. 
  • Postoperative Venous Thromboembolism in Patients Undergoing Abdominal Surgery for IBD: A Common but Rarely Addressed Problem. 
  • Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. 
  • Pyoderma gangrenosum: a reappraisal of associated systemic diseases. 
  • Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis. 
  • Receptors for sensory neuropeptides in human inflammatory diseases: implications for the effector role of sensory neurons. 
  • Research and the Internet. 
  • Richter's syndrome mimicking chronic colitis. A patient with diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. 
  • Short bowel syndrome after continence-preserving procedures. 
  • Simultaneous detection of eight analytes in human serum by two commercially available platforms for multiplex cytokine analysis. 
  • Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. 
  • Studying ulcerative colitis over the World Wide Web. 
  • Superior mesenteric artery syndrome following ileo-anal pouch procedure. 
  • Surveillance issues in inflammatory bowel disease: ulcerative colitis. 
  • The gasteointestinal oncology clinic. A multidisciplinary approach to cancer diagnosis and management at a University Medical Center. 
  • Therapy of inflammatory bowel disease: what to expect in the next decade. 
  • Toxic colitis with megacolon in a patient with malrotation. 
  • Transfusion-related acute lung injury (TRALI) complicating colectomy for ulcerative colitis. 
  • Tumor necrosis factor alpha and colitis-associated colon cancer. 
  • Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats. 
  • Women's health issues after ileal pouch surgery.